Showing results (31-40 of 42) with videos related to
Sort By:
Pageof 5
Journal of Chromatographic Science|November 19, 2014
An Economical Online Solid-Phase Extraction LC-MS/MS Method for Quantifying MethylprednisoloneXingjiang Hu, Yunliang Zheng, Guolan Wu, et al.Frontiers in Endocrinology|June 24, 2025
ER-α36 prevents high glucose-induced cellular senescence and apoptosis in renal tubular cellDehai Yu, Ling Luo, Yu Liang, et al.International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|November 20, 2025
Epstein-Barr virus in suspected intracranial infection: a multicenter, retrospective studyShengfeng Wang, Yuanxiu Huang, Nan Wang, et al.Drug Design, Development and Therapy|October 2, 2019
Bioequivalence Study Of A Fixed-Dose Combination Tablet Containing Melitracen 10 mg And Flupentixol 0.5 mg In Healthy Chinese Volunteers Under Fasted And Fed ConditionsLihua Wu, Chang Xu, Guolan Wu, et al.Journal of Alzheimer'S Disease : JAD|March 10, 2026
Nicotinamide mononucleotide supplementation modulates gut microbiota and metabolites to mitigate Alzheimer's disease pathology in APP/PS1 miceHuili Zhou, Xiaodong Zhao, Yuan Li, et al.Biochemical Pharmacology|December 20, 2025
IL-18 potentiates platelet activation and thrombosis through IL-18Rα-dependent MAPKs and PI3K/Akt signalingMaieryemu Waresi, Huili Zhou, Can Jiao, et al.Drug Design, Development and Therapy|July 17, 2023
Phase I, Single-Dose Study to Assess the Pharmacokinetics and Safety of Suramin in Healthy Chinese VolunteersGuolan Wu, Huili Zhou, Duo Lv, et al.Frontiers in Pharmacology|July 30, 2019
A Phase I Comparative Pharmacokinetic and Safety Study of Two Intravenous Formulations of Vinorelbine in Patients With Advanced Non-Small Cell Lung CancerGuolan Wu, Lihua Wu, Huili Zhou, et al.The Oncologist|October 30, 2016
A Phase I Study of the Safety and Pharmacokinetics of Higher-Dose Icotinib in Patients With Advanced Non-Small Cell Lung CancerJian Liu, Lihua Wu, Guolan Wu, et al.Frontiers in Immunology|January 10, 2022
Urinary Soluble CD163 Levels Predict IgA Nephropathy Remission StatusShaomin Gong, Shi Jin, Yang Li, et al.Pageof 5